Sai Parenterals Ltd
Sai Parenterals Ltd (SAIPARENT) last traded at ₹526, a market capitalisation of ₹2,324 crore, on a P/E of 112. Over the past 52 weeks the stock has ranged between ₹400 and ₹706. Sai Parenterals Ltd last reported results for the quarter ended Jun 2026, with sales of ₹179 crore and net profit of ₹7.92 crore. Sai Parenterals Ltd’s annual general meeting is scheduled for 10 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.
Sai Parenterals Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Sai Parenterals Ltd quarterly results
| ₹ crore | Jun 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Sales | 33.39 | 96.15 | 198 | 179 |
| Expenses | 28.65 | 99.71 | 172 | 155 |
| Operating profit | 4.74 | -3.56 | 26.1 | 23.52 |
| OPM % | 14.20% | -3.70% | 13.19% | 13.16% |
| Other income | 1.17 | 3.13 | 2.88 | 3.74 |
| Interest | 2.46 | 5.41 | 8.4 | 9.36 |
| Depreciation | 1.45 | 5.79 | 8.18 | 8.11 |
| Profit before tax | 2 | -11.63 | 12.4 | 9.79 |
| Tax % | 29.50% | -42.65% | -6.13% | 19.00% |
| Net profit | 1.42 | -6.66 | 13.16 | 7.92 |
| EPS (₹) | 0.52 | -1.80 | 2.98 | 1.79 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Sai Parenterals Ltd annual results
| ₹ crore | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 97 | 154 | 163 | 381 |
| Operating profit | 19 | 32 | 39 | 39 |
| OPM % | 19% | 21% | 24% | 10% |
| Net profit | 4 | 8 | 14 | 14 |
| EPS (₹) | 6.13 | 6.36 | 5.43 | 3.23 |
TTM is the trailing twelve months to the most recent quarter.
Sai Parenterals Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 58%
- TTM
- 134%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 48%
- TTM
- -1%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- 1 Year
- %
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 9%
- Last Year
- 5%
Sai Parenterals Ltd shareholding pattern
Promoters held 51.16% at Jun 2026, broadly unchanged since Mar 2026. FIIs 4.03% and DIIs 8.52%.
| % held | Mar 2026 | Jun 2026 |
|---|---|---|
| Promoters | 51.16% | 51.16% |
| FIIs | 5.73% | 4.03% |
| DIIs | 12.86% | 8.52% |
| Public | 30.25% | 36.29% |
| No. of shareholders | 7,687 | 9,312 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
When is Sai Parenterals Ltd’s AGM?
Sai Parenterals Ltd’s annual general meeting is scheduled for 10 Sept 2026.
- AGMAnnual General Meeting for FY 2025-26
See the full results calendar for every Indian company reporting in the next 30 days.
Sai Parenterals Ltd corporate filings
- Newspaper Publication of Notice of 25th Annual General Meeting of the Comapny for FY2025-26.Company Updatelow impact
Cruxal's analysis: Sai Parenterals Ltd has published a notice in newspapers regarding its 25th Annual…
Read the full analysis - Submission of Newspaper Publication in Form PAS-1 for change or variation in the objects of utilisation of IPO Proceeds.Company Updatelow impact
Cruxal's analysis: The company has submitted a newspaper publication in Form PAS-1, formally notifying…
Read the full analysis - Book closure intimation for 25th Annual General MeetingAGM/EGMlow impact
Cruxal's analysis: Sai Parenterals Limited has formally notified the exchanges regarding the closure of its…
Read the full analysis - Annual Report of the company for FY 2025-26Otherslow impact
Cruxal's analysis: Sai Parenterals Ltd has filed its Annual Report for the financial year 2025-26 as per…
Read the full analysis - Notice of 25th Annual General Meeting for the Financial Year 2025-26 scheduled to be held on 10th September, 2026.AGM/EGMhigh impact
Cruxal's analysis: Sai Parenterals Limited has scheduled its 25th Annual General Meeting for September 10…
Read the full analysis - Transcript of Earnings Call held on 12th August, 2026 at 02:30 PM (IST) for Quarter 1 of FY 2026-27.Company Updatehigh impact
Cruxal's analysis: Sai Parenterals Limited reported Q1 FY27 consolidated revenue of 182 crore and PAT of 8…
Read the full analysis - Audio Recording of the Earnings call held on 12th August, 2026Company Updatelow impact
Cruxal's analysis: Sai Parenterals Limited has formally disclosed the audio recording of its post-earnings…
Read the full analysis - Investor Presentation Q1 FY 2027Company Updatehigh impact
Cruxal's analysis: Sai Parenterals Limited has announced a strategic variation in the utilization of its IPO…
Read the full analysis - Press ReleaseCompany Updatelow impact
Cruxal's analysis: Sai Parenterals Ltd has submitted a press release under Regulation 30 of the SEBI (LODR)…
Read the full analysis - Statement on deviation or varition of fundsCompany Updatelow impact
Cruxal's analysis: Sai Parenterals Ltd has submitted a statement regarding the deviation or variation in the…
Read the full analysis - Outcome of Board Meeting held on 11th August, 2026 at the registered office of the company.Board Meetinghigh impact
Cruxal's analysis: Sai Parenterals Limited reported Q1 FY27 consolidated revenue of 178.67 crore and a net…
Read the full analysis - The Q1 earnings conference call for the FY 2026-27 is scheduled to be held on 12th August, 2026.Company Updatelow impact
Cruxal's analysis: Sai Parenterals Limited has announced an earnings conference call to discuss its…
Read the full analysis - Sai Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve 1. Un-audited Financial Results ....Board Meetinglow impact
Cruxal's analysis: Sai Parenterals Limited has announced that its Board of Directors will convene a meeting…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Sai Parenterals Ltd
Cruxal reads every Sai Parenterals Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.